Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Stoke Therapeutics Inc.

    NASDAQ: STOK · Real-Time Price · USD
    11.70
    0.17 (1.47%)
    At close: Jun 16, 2025, 3:59 PM
    11.68
    -0.17%
    Pre-market: Jun 17, 2025, 07:10 AM EDT

    Stoke Therapeutics Statistics

    Share Statistics

    Stoke Therapeutics has 54.6M shares outstanding. The number of shares has increased by 1.62% in one year.

    Shares Outstanding

    n/a
    		 54.6M

    Shares Change (YoY)

    n/a
    		 1.62%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 45.2M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,641

    FTD / Avg. Volume

    n/a
    		 0.32%

    Short Selling Information

    The latest short interest is 12.03M, so 22.03% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 12.03M

    Short % of Shares Out

    n/a
    		 22.03%

    Short % of Float

    n/a
    		 26.65%

    Short Ratio (days to cover)

    n/a
    		 20.89

    Valuation Ratios

    The PE ratio is -6.69 and the forward PE ratio is -4.26. Stoke Therapeutics's PEG ratio is 0.22.

    PE Ratio

    n/a
    		 -6.69

    Forward PE

    n/a
    		 -4.26

    PS Ratio

    n/a
    		 16.3

    Forward PS

    n/a
    		 2.9

    PB Ratio

    n/a
    		 2.6

    P/FCF Ratio

    n/a
    		 -6.84

    PEG Ratio

    n/a
    		 0.22
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Stoke Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.81, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 5.81

    Quick Ratio

    n/a
    		 5.81

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.02

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 -8.02

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $285,585.94

    Profits Per Employee

    n/a
    		 $-695,164.06

    Employee Count

    n/a
    		 128

    Asset Turnover

    n/a
    		 0.13

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -25% in the last 52 weeks. The beta is 1.1, so Stoke Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.1

    52-Week Price Change

    n/a
    		 -25%

    50-Day Moving Average

    n/a
    		 9.3

    200-Day Moving Average

    n/a
    		 10.78

    Relative Strength Index (RSI)

    n/a
    		 69.89

    Average Volume (20 Days)

    n/a
    		 818,006

    Income Statement

    In the last 12 months, Stoke Therapeutics had revenue of 36.55M and earned -88.98M in profits. Earnings per share was -1.65.

    Revenue

    n/a
    		 36.55M

    Gross Profit

    n/a
    		 32.11M

    Operating Income

    n/a
    		 -101.37M

    Net Income

    n/a
    		 -88.98M

    EBITDA

    n/a
    		 -99.19M

    EBIT

    n/a
    		 -101.37M

    Earnings Per Share (EPS)

    n/a
    		 -1.65
    Full Income Statement

    Balance Sheet

    The company has 127.98M in cash and 2.32M in debt, giving a net cash position of 125.66M.

    Cash & Cash Equivalents

    n/a
    		 127.98M

    Total Debt

    n/a
    		 2.32M

    Net Cash

    n/a
    		 125.66M

    Retained Earnings

    n/a
    		 -490.83M

    Total Assets

    n/a
    		 406.89M

    Working Capital

    n/a
    		 331.05M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -86.85M and capital expenditures -203K, giving a free cash flow of -87.05M.

    Operating Cash Flow

    n/a
    		 -86.85M

    Capital Expenditures

    n/a
    		 -203K

    Free Cash Flow

    n/a
    		 -87.05M

    FCF Per Share

    n/a
    		 -1.61
    Full Cash Flow Statement

    Margins

    Gross margin is 87.85%, with operating and profit margins of -277.31% and -243.42%.

    Gross Margin

    n/a
    		 87.85%

    Operating Margin

    n/a
    		 -277.31%

    Pretax Margin

    n/a
    		 -243.42%

    Profit Margin

    n/a
    		 -243.42%

    EBITDA Margin

    n/a
    		 -271.36%

    EBIT Margin

    n/a
    		 -277.31%

    FCF Margin

    n/a
    		 -238.15%

    Dividends & Yields

    STOK does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for STOK is $23, which is 96.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $23

    Price Target Difference

    n/a
    		 96.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 26.72

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist